SinoMab BioScience Limited reported that its extraordinary general meeting held on 7 September 2026 approved the proposed disposal under the Sale and Purchase Agreement with full shareholder support.

The sole ordinary resolution—seeking to confirm, approve and ratify the Disposal agreement and to authorise any director to execute related documents—received 315.77 million votes in favour, representing 100.00% of votes cast. No votes were recorded against the motion.

Voting Base and Participation • Total shares in issue as of the meeting date: 1.39 billion • Shares entitled to vote: 1.39 billion (the company holds no treasury shares) • No shareholders were required to abstain, and no special voting restrictions applied.

Governance and Oversight Eight of the nine board members attended the meeting in person or electronically. Computershare Hong Kong Investor Services Limited acted as the independent scrutineer overseeing the poll.

Outcome With unanimous shareholder backing, the Disposal was formally ratified, granting directors authority to proceed with all necessary implementation steps.